Hong Zhu on Muck Rack

Hong Zhu

  • Editor in Chief, Modern Transmission
As seen in: AIChE Journal, Color Research & Application, Nature, Wiley Online Library, Cornell Hospitality Quarterly, Memory Studies, Annals of the Rheumatic Diseases, BMJ Open, Frontiers, Frontiers in Immunology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hong

Contact Hong, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

NOP2-mediated m5C methylation impairs mitophagy and aggravates acute lung injury by targeting PINK1

|
By Xiaoyuan Chen, Rui Zhao, Hong Zhu, Yang Lu
| Nature Verified
Abstract Sepsis-induced acute lung injury (ALI) involves complex pathological mechanisms. 5-methylcytosine (m5C) RNA modification, catalyzed by methyltransferases like NOP2, plays a crucial role in regulating inflammation and cellular processes. However, the role of NOP2 and its potential regulation of m5C modification in sepsis-induced ALI remains unclear. An in vitro ALI model was established by treating human pulmonary epithelial A549 cells with lipopolysaccharide (LPS).
Open in Who Shared Issue with article?

Evaluation of the predictive accuracy of nine staging systems in patients with hepatocellular carcinoma: a multicenter, retrospective study in China

|
By Shibo Wang, Yu Li, Shuang Leng, Hong Zhu, Jing Lv, Dayong Zheng, Haifeng Lin, Jianhong Zhong, Ming Zhao, Jun Xue, Peng Huang, Zhiyu Chen, Qian Zhu, Weijia Fang, Xiufeng Liu, Nanya Wang
| Nature Verified
Abstract There are several staging systems for hepatocellular carcinoma (HCC); however, the best prognostic system for Chinese patients has not been established. The aim of this study was to evaluate nine staging systems and identify the best prognostic staging system for Chinese patients with HCC. This retrospective study included 1,495 patients with HCC from 2012 to 2022 in 17 hospitals in China.
Open in Who Shared Issue with article?

Tumor treating field plus chemotherapy for locally advanced pancreatic adenocarcinoma: An international cost-effectiveness analysis

|
By Kun Liu, Youwen Zhu, Manting Zeng, Hong Zhu
| Nature Verified
Abstract The PANOVA-3 trial has demonstrated that adding tumor treating fields (TTFields) to standard chemotherapy improves survival outcomes in locally advanced pancreatic adenocarcinoma (LA-PAC). However, given the high cost of such novel therapies, it is essential to evaluate their economic impact to ensure a balanced understanding of their clinical and financial value.
Open in Who Shared Issue with article?
See all 215 licensed articles (236 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified